Document is current
Any future updates will be listed below
-
Authors
Elías, I.
Ortega-Joaquín, N.
de la Cueva, P.
del Pozo, L.J.
Moreno-Ramírez, D.
Boada, A.
Aguilar, M.
Mirada, A.
Mosquera, E.
Gibbons, C.
Oyagüez, I.
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain
Journal Title: Actas Dermo-Sifiliográficas (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.adengl.2016.05.022
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2016.03.004
Content Type: article
Copyright: © 2016 Elsevier España, S.L.U. and AEDV.
